Discontinuation report PROSTIN F2 ALPHA

Last updated on 2019-02-11 History
Report ID 48996
Drug Identification Number 00318736
Brand name PROSTIN F2 ALPHA
Common or Proper name PROSTIN F2A
Company Name PFIZER CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) DINOPROST
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRA-AMNIOTIC
Packaging size 1 x 1ml
ATC code G02AD
ATC description UTEROTONICS
Reason for discontinuation Other (Please describe in comments)
Anticipated discontinuation date
Actual discontinuation date 2018-09-30
Remaining supply date 2018-09-30
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments The product discontinuation is due to low market demand.
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2019-02-11 French Compare
v3 2019-02-11 English Compare
v2 2018-05-10 French Compare
v1 2018-05-10 English Compare

Showing 1 to 4 of 4